pCPA Activity Overview
Status | Total Negotiations | Summary |
---|---|---|
Active Negotiations | 45 | Non-oncology: 29 Oncology: 16 |
Under Consideration for Negotiation | 17 | Non-oncology: 11 Oncology: 6 |
Completed Negotiations | 722 | With Letter of Intent: 621 Without agreement: 101 |
Negotiations That Were Not Pursued | 108 |
pCPA Activity in the last four weeks
Activity for the last four weeks. Please note that these updates may take one to two weeks to be processed.
Engagement Letters Issued in the last four weeks
Brand Name | Manufacturer | Indication | Engagement Date |
---|---|---|---|
Imbruvica | Janssen Inc. | Chronic lymphocytic leukemia (CLL), in adult patients with previously untreated CLL, including those with 17p deletion | |
Tyenne | Fresenius Kabi Canada Ltd. | Multiple Indications | |
Imbruvica | Janssen Inc. | Waldenström's Macroglobulinemia | |
Bimzelx | UCB Canada Inc. | Ankylosing spondylitis | |
Bimzelx | UCB Canada Inc. | Psoriatic Arthritis | |
Awiqli | Novo Nordisk Canada Inc. | Diabetes Mellitus, Type 2 |